Atlas Trials

A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

Clinical trial NCT02688491 · UNKNOWN

Trial details

NCT number
NCT02688491
Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal NeoplasmsTargeted Molecular Therapy
Start date
2016-07-01
Primary completion
2026-07-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.